962
Views
0
CrossRef citations to date
0
Altmetric
Letter to the Editor

Assessment of patient-reported outcomes at 24 weeks of treatment with tralokinumab for atopic dermatitis: a multicentric real-life experience

, , , , , & show all
Article: 2285243 | Received 06 Nov 2023, Accepted 13 Nov 2023, Published online: 20 Nov 2023